
Despite Gazyva being the first drug accepted to treat this type of nephropathy, it’s already approved for a host of other conditions.
ISMP is expanding its outreach by introducing a web site for consumers this summer.
Until now, the
To see more Daily News articles,
To go to the Drug Topics homepage,






